10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO, CA
Announces Refinancing of Credit Agreement, Extending Maturity to 2032
Maravai LifeSciences Holds 2026 Annual Meeting; Shareholder Votes Recorded
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Financial Results, Press Release
Board Restructuring - Benjamin Daverman, Jessica Hopfield, and Murali Prahala...
Reports Second Quarter 2025 Financial Results
Q1
FY 2024
Q3
Q2
Notice of Late Filing for Annual Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
S-1
Direct Registration System
Amended Registration Statement for Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Submission Upload
Correspondence